Financial Performance - The company's revenue for Q1 2023 was ¥871,392,103.77, a decrease of 32.54% compared to ¥1,291,651,979.48 in the same period last year[7] - Net profit attributable to shareholders was ¥80,167,406.63, down 48.42% from ¥155,418,080.94 year-on-year[7] - The basic earnings per share decreased by 50% to ¥0.10 from ¥0.20 in the previous year[7] - Operating revenue for the period was ¥871,392,103.77, a decrease of 32.54% compared to ¥1,291,651,979.48 in the same period last year[24] - Total profit for the current period is 101,418,723.28, down from 185,136,546.93, reflecting a decline of 45.4%[51] - Operating profit for the current period is 101,194,876.81, down 45.5% from 185,581,855.98 in the previous period[51] - Net profit for the current period is 89,588,368.31, a decrease of 43.7% compared to 159,336,947.25 in the previous period[51] - Research and development expenses amount to 84,437,708.78, slightly down from 87,300,973.94, indicating a decrease of 3.2%[51] Assets and Liabilities - The company's total assets increased by 2.43% to ¥7,945,774,456.02 from ¥7,757,264,166.77 at the end of the previous year[7] - The company reported a significant increase in intangible assets by 130.10% to ¥178,208,624.90 due to the merger with Shanghai Hengjing[9] - The goodwill increased by 33.36% to ¥300,621,875.99, attributed to the acquisition of Shanghai Hengjing and Inov 3[9] - The company’s receivables increased by 30.25% to ¥58,976,107.30, mainly due to the rise in bank acceptance bills[9] - The company’s long-term borrowings rose by 36.42% to ¥770,431,655.20, reflecting new bank loans during the period[9] - The total liabilities as of March 31, 2023, amounted to CNY 2,408,456,483.83, up from CNY 2,297,890,286.92 at the start of the year, marking an increase of about 4.8%[48] - The non-current liabilities totaled CNY 963,441,273.54, compared to CNY 717,953,595.48 at the beginning of the year, showing a significant increase of approximately 34.2%[48] - The company's retained earnings reached CNY 2,716,354,441.74, up from CNY 2,636,187,035.11, indicating an increase of about 3%[48] Cash Flow - The cash flow from operating activities was ¥92,776,357.72, a decline of 39.87% compared to ¥154,287,623.49 in the same period last year[7] - Cash flow from investing activities showed a net outflow of ¥400,615,033.74, a decrease of 351.97% compared to a net inflow of ¥158,993,556.68 in the previous year[25] - Cash flow from financing activities decreased by 86.78% to ¥9,569,271.76 from ¥72,364,893.72, primarily due to repayment of bank loans and interest[25] - Cash inflow from investment activities totals 370,067,615.16, up from 250,118,149.55, reflecting an increase of 48.0%[54] - Net cash flow from investment activities was -$400.62 million, compared to $158.99 million in the prior period[55] - Cash inflow from financing activities amounted to $216.49 million, up from $116.06 million year-over-year[55] - Net cash flow from financing activities was $9.57 million, down from $72.36 million in the prior period[55] - The ending balance of cash and cash equivalents was $460.16 million, down from $1.54 billion at the end of the previous period[55] Operational Metrics - Operating costs decreased by 34.62% to ¥611,034,991.15 from ¥934,654,619.64, primarily due to the decline in sales revenue[24] - Financial expenses increased by 253.14% to ¥19,168,754.08, mainly due to increased exchange losses[24] - Fair value changes in investment income rose by 112.27% to ¥23,292,819.19 from ¥10,973,128.24, influenced by the fair value changes of forward foreign exchange contracts[24] - The company reported a decrease in employee compensation payable from CNY 105,791,801.16 to CNY 70,141,149.82, a reduction of approximately 33.8%[40] - The contract liabilities decreased from CNY 161,024,581.58 to CNY 117,783,959.95, reflecting a decline of about 26.7%[40] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 29,378, with the largest shareholder holding 48.82%[25] - The company plans to establish an innovation research institute in collaboration with Tianjin University to leverage its strengths in talent and research[36] - The company has established a research institute for brain-computer interaction and smart health, contributing ¥7 million as initial funding[28]
盈趣科技(002925) - 2023 Q1 - 季度财报